OnKure Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OKUR research report →
About the company
OnKure, Inc. , established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases.
- CEO
- Nicholas A. Saccomano
- IPO
- 2021
- Employees
- 46
- HQ
- Boulder, CO, US
Price Chart
- Market Cap
- $62.63M
- P/E
- -1.06
- P/S
- 0.00
- P/B
- 0.34
- EV/EBITDA
- 2.23
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -61.02%
- ROIC
- -33.32%
- Revenue
- $0 · 0.00%
- Net Income
- $-59,517,000 · -12.99%
- EPS
- $-4.40 · -11.39%
- Op Income
- $-62,950,000
- FCF YoY
- -1.38%
- 52W High
- $5.38
- 52W Low
- $1.91
- 50D MA
- $4.24
- 200D MA
- $3.41
- Beta
- 0.27
- Avg Volume
- 300.80K
Get TickerSpark's AI analysis on OKUR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 22, 26 | Saccomano Nicholas A | sell | 86 |
| Jun 22, 26 | Leverone Jason A. | sell | 303 |
| Jun 4, 26 | Mathers Edward T | other | 7,650 |
| Jun 4, 26 | Ratcliffe Liam | other | 1,275 |
| Jun 4, 26 | Phillips Andrew John | other | 7,650 |
| Jun 4, 26 | Jansen Valerie Malyvanh | other | 7,650 |
| Jun 4, 26 | GREY MICHAEL G | other | 7,650 |
| Jun 4, 26 | Carruthers R Michael | other | 7,650 |
| Mar 31, 26 | AI Biotechnology LLC | other | 0 |
| Mar 31, 26 | AI Biotechnology LLC | other | 5,640,222 |
Our OKUR coverage
Recent articles, reports, and earnings notes.
No research on OKUR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OKUR report →Similar companies
Peers in the same neighborhood.